FDA NDC Directory · JSON-LD · Markdown

EGATEN

NDC 0078-0937 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nametriclabendazole
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA208711
Dosage form / routeTABLET · ORAL
Active ingredientsTRICLABENDAZOLE (250 mg/1)
Marketing started20190213
Package count1

External sources

Source: openFDA. Public-domain (CC0).